Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases

Cardiometabolic diseases are characterized as a combination of multiple risk factors for cardiovascular disease (CVD) and metabolic diseases including diabetes mellitus and dyslipidemia. Cardiometabolic diseases are closely associated with cell glucose and lipid metabolism, inflammatory response and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Li, Chao, Yang, Jie, Wang, Yu, Qi, Yingzi, Yang, Wenqing, Li, Yunlun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2020
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479173/
https://ncbi.nlm.nih.gov/pubmed/32982723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01247
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk